{
    "nctId": "NCT05289466",
    "briefTitle": "Oncoplastic Partial Mastectomy With Intraoperative Radiation Therapy (IORT) in Early Stage Breast Cancer Patients With Prior History of Chest Wall Radiation.",
    "officialTitle": "Oncoplastic Partial Mastectomy With Intraoperative Radiation Therapy (IORT) in Early Stage Breast Cancer Patients With Prior History of Chest Wall Radiation",
    "overallStatus": "RECRUITING",
    "conditions": "IORT-Intra-Operative Radiation Therapy",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "Cosmetic Outcomes as evaluated using BREAST-Q questionnaire as a measure of patient-reported ratings.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \u2265 50 y.o.\n* Histologically proven in situ and invasive ductal or lobular breast recurrence\n* Prior history of whole breast/chest wall radiation therapy\n* Disease span \u2264 3 cm, unifocal\n* No nodal disease (N0)\n* No evidence of metastatic disease (M0)\n* Time from initial BCT should be \u2265 1 year\n* Patients have refused the standard of care of mastectomy\n* Skin distance of \u2265 0.8 cm between applicator and skin\n\nExclusion Criteria:\n\n* Multifocal and/or multicenter recurrence\n\n  * N1-3 status: Regional cytological or histologically proven node recurrence\n  * M1 status: Metastatic disease\n  * cT4 (Skin or muscle involvement) or Paget's disease of the nipple\n  * Patients undergoing mastectomy\n  * Patients undergoing neoadjuvant systemic therapy\n  * Connective tissue disease or scleroderma, contraindicating radiotherapy",
    "sex": "FEMALE",
    "minimumAge": "50 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}